RT Journal Article
SR Electronic
T1 What is the relationship between validated frailty scores and mortality for adults with COVID-19 in acute hospital care? A systematic review
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.13.20231365
DO 10.1101/2020.11.13.20231365
A1 Theodore D. Cosco
A1 John Best
A1 Daniel Davis
A1 Daniele Bryden
A1 Suzanne Arkill
A1 James van Oppen
A1 Indira Riadi
A1 Simon Conroy
YR 2020
UL http://medrxiv.org/content/early/2020/12/18/2020.11.13.20231365.abstract
AB Background & aim The aim of this systematic review was to quantify the association between frailty and COVID-19 in relation to mortality in hospitalised patients.Methods Medline, Embase, Web of Science and the grey literature were searched for papers from inception to 10th September 2020; the search was re-run in Medline up until the 9th December 2020. Screening, data extraction and quality grading were undertaken by two reviewers. Results were summarised using descriptive statistics, including a meta-analysis of overall mortality; the relationships between frailty and COVID-19 mortality were summarised narratively.Results 2286 papers were screened resulting in 26 being included in the review. Most studies were from Europe, half from the UK, and one from Brazil; the median sample size was 242.5, median age 73.1 and 43.5% were female. 22/26 used the Clinical Frailty Scale; reported mortality ranged from 14 to 65%. Most, but not all studies showed an association between increasing frailty and a greater risk of dying. Two studies indicated a sub-additive relationship between frailty, COVID-19 and death, and two studies showed no association.Conclusions Whilst the majority of studies have shown a positive association between COVID-19 related death and increasing frailty, some studies suggested a more nuanced understanding of frailty and outcomes in COVID-19 is needed. Clinicians should exert caution in placing too much emphasis on the influence of frailty alone when discussing likely prognosis in older people with COVID-19 illness.Key pointsFrailty is being used to assess the risk of dying from COVID-19Emerging studies demonstrate a complex relationship between frailty and COVID-19 related deathsClinicians should exert caution in placing too much emphasis on the influence of frailty in older people with COVID-19Researchers should ensure that frailty scales are used as designed when planning and reporting future research.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=200445 Funding StatementDaniel Davis is funded through a Wellcome Intermediate Clinical Fellowship (WT107467). Theodore D Cosco is funded through a Michael Smith Foundation for Health Research Scholar Award (SCH-2020-0490). James van Oppen is funded through a National Institute for Health Research Doctoral Research Fellowship (NIHR300901).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethical approval was required for this work as it was a systematic review of published studies.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll of the primary studies are already available in the public domain and referenced in the manuscript.